Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-001472
Filing Date
2019-01-03
Accepted
2019-01-03 19:53:29
Documents
1
Period of Report
2019-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5789
  Complete submission text file 0001209191-19-001472.txt   7463
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address
GIVEN BRUCE D (Reporting) CIK: 0001219384 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38042 | Film No.: 19507972